The Securities and Exchange Commission has not necessarily reviewed the information in this filing and has not determined if it is accurate and complete. | |||||||||||||||||
|
UNITED STATES SECURITIES AND EXCHANGE COMMISSION Washington, D.C. 20549 FORM 13F FORM 13F INFORMATION TABLE |
|
||||||||||||||||
| COLUMN 1 | COLUMN 2 | COLUMN 3 | COLUMN 4 | COLUMN 5 | COLUMN 6 | COLUMN 7 | COLUMN 8 | ||||
| VALUE | SHRS OR | SH/ | PUT/ | INVESTMENT | OTHER | VOTING AUTHORITY | |||||
| NAME OF ISSUER | TITLE OF CLASS | CUSIP | (x$1000) | PRN AMT | PRN | CALL | DISCRETION | MANAGER | SOLE | SHARED | NONE |
| AKARI THERAPEUTICS PLC | SPONSORED ADR | 00972G108 | 1,461 | 100,750 | SH | SOLE | 100,750 | 0 | 0 | ||
| ARRAY BIOPHARMA INC | NOTE | 04269XAA3 | 21,633 | 22,534 | PRN | SOLE | 22,534 | 0 | 0 | ||
| ASSEMBLY BIOSCIENCES INC | COM | 045396108 | 15,758 | 2,098,302 | SH | SOLE | 2,098,302 | 0 | 0 | ||
| ATYR PHARMA INC | COM | 002120103 | 7,770 | 790,462 | SH | SOLE | 790,462 | 0 | 0 | ||
| CALITHERA BIOSCIENCES INC | COM | 13089P101 | 3,183 | 415,480 | SH | SOLE | 415,480 | 0 | 0 | ||
| CELLADON CORP | COM | 15117E107 | 4,179 | 2,843,170 | SH | SOLE | 2,843,170 | 0 | 0 | ||
| COLLEGIUM PHARMACEUTICAL INC | COM | 19459J104 | 12,791 | 465,118 | SH | SOLE | 465,118 | 0 | 0 | ||
| CYTOKINETICS INC | COM | 23282W605 | 14,840 | 1,418,700 | SH | SOLE | 1,418,700 | 0 | 0 | ||
| CYTOKINETICS INC | COM | 23282W905 | 2,977 | 284,600 | SH | Call | SOLE | 284,600 | 0 | 0 | |
| EPIZYME INC | COM | 29428V104 | 11,196 | 698,900 | SH | SOLE | 698,900 | 0 | 0 | ||
| FIBROGEN INC | COM | 31572Q808 | 37,066 | 1,216,473 | SH | SOLE | 1,216,473 | 0 | 0 | ||
| FIVE PRIME THERAPEUTICS INC | COM | 33830X104 | 29,839 | 719,000 | SH | SOLE | 719,000 | 0 | 0 | ||
| FLEX PHARMA INC | COM | 33938A105 | 9,899 | 795,088 | SH | SOLE | 795,088 | 0 | 0 | ||
| FORWARD PHARMA A/S | SPONSORED ADR | 34986J105 | 1,900 | 100,017 | SH | SOLE | 100,017 | 0 | 0 | ||
| GALAPAGOS | SPONSORED ADR | 36315X101 | 10,524 | 167,361 | SH | SOLE | 167,361 | 0 | 0 | ||
| GENVEC INC | COM | 37246C307 | 3,534 | 1,920,913 | SH | SOLE | 1,920,913 | 0 | 0 | ||
| GILEAD SCIENCES INC | COM | 375558903 | 1,194 | 11,800 | SH | Call | SOLE | 11,800 | 0 | 0 | |
| IRONWOOD PHARMACEUTICALS | COM CL A | 46333X108 | 9,522 | 821,531 | SH | SOLE | 821,531 | 0 | 0 | ||
| JAZZ PHARMACEUTICALS | COM | G50871905 | 26,594 | 189,200 | SH | Call | SOLE | 189,200 | 0 | 0 | |
| KINDRED BIOSCIENCES INC | COM | 494577109 | 4,871 | 1,432,765 | SH | SOLE | 1,432,765 | 0 | 0 | ||
| KITE PHARMA INC | COM | 49803L109 | 10,229 | 166,000 | SH | SOLE | 166,000 | 0 | 0 | ||
| KURA ONCOLOGY INC | COM | 50127T109 | 20,580 | 2,450,000 | SH | SOLE | 2,450,000 | 0 | 0 | ||
| NABRIVA THERAPEUTICS AG | SPONSORED ADR | 62957M104 | 7,931 | 838,680 | SH | SOLE | 838,680 | 0 | 0 | ||
| NEPHROGENEX INC | COM | 640667101 | 941 | 588,235 | SH | SOLE | 588,235 | 0 | 0 | ||
| OVASCIENCE INC | COM | 69014Q101 | 4,152 | 424,979 | SH | SOLE | 424,979 | 0 | 0 | ||
| QLT INC | COM | 746927102 | 266 | 100,000 | SH | SOLE | 100,000 | 0 | 0 | ||
| RETROPHIN INC | COM | 761299106 | 23,618 | 1,224,384 | SH | SOLE | 1,224,384 | 0 | 0 | ||
| RETROPHIN INC | COM | 761299906 | 4,709 | 244,100 | SH | Call | SOLE | 244,100 | 0 | 0 | |
| VALEANT PHARMACEUTICALS INTL | COM | 91911K902 | 12,859 | 126,500 | SH | Call | SOLE | 126,500 | 0 | 0 | |
| ZAFGEN INC | COM | 98885E103 | 2,321 | 369,000 | SH | SOLE | 369,000 | 0 | 0 | ||
| ZAFGEN INC | COM | 98885E903 | 63 | 10,000 | SH | Call | SOLE | 10,000 | 0 | 0 | |